PRRT2 and COVID-19: The percentage of patients in the germicidal lamp group before COVID-19 (5, 3.1%) was lower than the percentage of patients in the germicidal lamp group after COVID-19 began (15, 10.2%); thus, the incidence of PKC in the germicidal lamp group increased significantly after COVID-19 began (P = 0.03).